Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant

To compare outcomes in recipients of expanded criteria donor (ECD) versus standard criteria donor (SCD) kidneys at a single center using a standardized approach with similar immunosuppression. Expanded criteria deceased organ donors (ECD) are a source of kidneys that permit more patients to benefit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgery 2004-05, Vol.239 (5), p.688-697
Hauptverfasser: Stratta, Robert J, Rohr, Michael S, Sundberg, Aimee K, Armstrong, Greg, Hairston, Gloria, Hartmann, Erica, Farney, Alan C, Roskopf, Julie, Iskandar, Samy S, Adams, Patricia L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 697
container_issue 5
container_start_page 688
container_title Annals of surgery
container_volume 239
creator Stratta, Robert J
Rohr, Michael S
Sundberg, Aimee K
Armstrong, Greg
Hairston, Gloria
Hartmann, Erica
Farney, Alan C
Roskopf, Julie
Iskandar, Samy S
Adams, Patricia L
description To compare outcomes in recipients of expanded criteria donor (ECD) versus standard criteria donor (SCD) kidneys at a single center using a standardized approach with similar immunosuppression. Expanded criteria deceased organ donors (ECD) are a source of kidneys that permit more patients to benefit from transplantation. ECD is defined as all deceased donors older than 60 years and donors older than 50 years with 2 of the following: hypertension, stroke as the cause of death, or pre-retrieval serum creatinine (SCr) greater than 1.5 mg/dl. We retrospectively studied 90 recipients of adult deceased donor kidneys transplanted from October 1, 2001 to February 17, 2003, including 37 (41%) from ECDs and 53 (59%) from SCDs. ECD kidneys were used by matching estimated renal functional mass to recipient need, including the use of dual kidney transplants (n = 7). ECD kidney recipients were further selected on the basis of older age, HLA-matching, low allosensitization, and low body mass index. All patients received a similar immunosuppressive regimen. Minimum follow up was 9 months. There were significant differences in donor and recipient characteristics between ECD and SCD transplants. Patient (99%) and kidney graft survival (88%) rates and morbidity were similar between the 2 groups, with a mean follow-up of 16 months. Initial graft function and the mean 1-week and 1-, 3-, 6-, 12-, and 18-month SCr levels were similar among groups. The use of ECD kidneys at our center effectively doubled our transplant volume within 1 year. A systematic approach to ECD kidneys based on nephron mass matching and nephron sparing measures may provide optimal utilization with short-term outcomes and renal function comparable to SCD kidneys.
doi_str_mv 10.1097/01.sla.0000124296.46712.67
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1356277</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71833513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-60299d9cbd42daf3fa6cf2127989883278bdc155f030dab3192a01ccd28ed7813</originalsourceid><addsrcrecordid>eNpVkcGOFCEURYnROO3oLxjiwl2VPKgqwIWJmeg4ySRudE0ooHrQaiiBGh2_wk8e2u447duweOfe-8hF6BWQFojkbwi0edYtqQO0o3Jou4EDbQf-CG2gp6IB6MhjtKkAazrJ6Bl6lvO3ineC8KfoDHoiqORsg_5cBZOczs7i794Gd4dL0iEvsw5FFx8DXouf_W8fttj9WnSwlTTJF5e8xtaZgzamrQ7YxhBTxj99ucHJ5XUuGZu4W3TS4-xwiTiX6qDTqcVecxL6HD2Z9Jzdi-N7jr5-_PDl4lNz_fny6uL9dWM62pVmIFRKK81oO2r1xCY9mIkC5VJIIRjlYrQG-n4ijFg9MpBUEzDGUuEsF8DO0buD77KOO2eNC_WGWS3J73S6U1F79f8m-Bu1jbcKWD9QzqvB66NBij9Wl4va-WzcXD_h4poVB8FYD6yCbw-gSTHn5KZ_IUDUvlBFQNVC1UOh6m-hatinvDw980F6bJDdA4zdo5A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71833513</pqid></control><display><type>article</type><title>Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Stratta, Robert J ; Rohr, Michael S ; Sundberg, Aimee K ; Armstrong, Greg ; Hairston, Gloria ; Hartmann, Erica ; Farney, Alan C ; Roskopf, Julie ; Iskandar, Samy S ; Adams, Patricia L</creator><creatorcontrib>Stratta, Robert J ; Rohr, Michael S ; Sundberg, Aimee K ; Armstrong, Greg ; Hairston, Gloria ; Hartmann, Erica ; Farney, Alan C ; Roskopf, Julie ; Iskandar, Samy S ; Adams, Patricia L</creatorcontrib><description>To compare outcomes in recipients of expanded criteria donor (ECD) versus standard criteria donor (SCD) kidneys at a single center using a standardized approach with similar immunosuppression. Expanded criteria deceased organ donors (ECD) are a source of kidneys that permit more patients to benefit from transplantation. ECD is defined as all deceased donors older than 60 years and donors older than 50 years with 2 of the following: hypertension, stroke as the cause of death, or pre-retrieval serum creatinine (SCr) greater than 1.5 mg/dl. We retrospectively studied 90 recipients of adult deceased donor kidneys transplanted from October 1, 2001 to February 17, 2003, including 37 (41%) from ECDs and 53 (59%) from SCDs. ECD kidneys were used by matching estimated renal functional mass to recipient need, including the use of dual kidney transplants (n = 7). ECD kidney recipients were further selected on the basis of older age, HLA-matching, low allosensitization, and low body mass index. All patients received a similar immunosuppressive regimen. Minimum follow up was 9 months. There were significant differences in donor and recipient characteristics between ECD and SCD transplants. Patient (99%) and kidney graft survival (88%) rates and morbidity were similar between the 2 groups, with a mean follow-up of 16 months. Initial graft function and the mean 1-week and 1-, 3-, 6-, 12-, and 18-month SCr levels were similar among groups. The use of ECD kidneys at our center effectively doubled our transplant volume within 1 year. A systematic approach to ECD kidneys based on nephron mass matching and nephron sparing measures may provide optimal utilization with short-term outcomes and renal function comparable to SCD kidneys.</description><identifier>ISSN: 0003-4932</identifier><identifier>EISSN: 1528-1140</identifier><identifier>DOI: 10.1097/01.sla.0000124296.46712.67</identifier><identifier>PMID: 15082973</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Creatinine - blood ; Female ; Graft Survival ; Humans ; Immunosuppressive Agents - therapeutic use ; Kidney Transplantation - immunology ; Kidney Transplantation - methods ; Kidney Transplantation - statistics &amp; numerical data ; Male ; Middle Aged ; Original and Discussions ; Retrospective Studies ; Tissue Donors ; Treatment Outcome</subject><ispartof>Annals of surgery, 2004-05, Vol.239 (5), p.688-697</ispartof><rights>2004 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-60299d9cbd42daf3fa6cf2127989883278bdc155f030dab3192a01ccd28ed7813</citedby><cites>FETCH-LOGICAL-c424t-60299d9cbd42daf3fa6cf2127989883278bdc155f030dab3192a01ccd28ed7813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356277/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356277/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15082973$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stratta, Robert J</creatorcontrib><creatorcontrib>Rohr, Michael S</creatorcontrib><creatorcontrib>Sundberg, Aimee K</creatorcontrib><creatorcontrib>Armstrong, Greg</creatorcontrib><creatorcontrib>Hairston, Gloria</creatorcontrib><creatorcontrib>Hartmann, Erica</creatorcontrib><creatorcontrib>Farney, Alan C</creatorcontrib><creatorcontrib>Roskopf, Julie</creatorcontrib><creatorcontrib>Iskandar, Samy S</creatorcontrib><creatorcontrib>Adams, Patricia L</creatorcontrib><title>Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant</title><title>Annals of surgery</title><addtitle>Ann Surg</addtitle><description>To compare outcomes in recipients of expanded criteria donor (ECD) versus standard criteria donor (SCD) kidneys at a single center using a standardized approach with similar immunosuppression. Expanded criteria deceased organ donors (ECD) are a source of kidneys that permit more patients to benefit from transplantation. ECD is defined as all deceased donors older than 60 years and donors older than 50 years with 2 of the following: hypertension, stroke as the cause of death, or pre-retrieval serum creatinine (SCr) greater than 1.5 mg/dl. We retrospectively studied 90 recipients of adult deceased donor kidneys transplanted from October 1, 2001 to February 17, 2003, including 37 (41%) from ECDs and 53 (59%) from SCDs. ECD kidneys were used by matching estimated renal functional mass to recipient need, including the use of dual kidney transplants (n = 7). ECD kidney recipients were further selected on the basis of older age, HLA-matching, low allosensitization, and low body mass index. All patients received a similar immunosuppressive regimen. Minimum follow up was 9 months. There were significant differences in donor and recipient characteristics between ECD and SCD transplants. Patient (99%) and kidney graft survival (88%) rates and morbidity were similar between the 2 groups, with a mean follow-up of 16 months. Initial graft function and the mean 1-week and 1-, 3-, 6-, 12-, and 18-month SCr levels were similar among groups. The use of ECD kidneys at our center effectively doubled our transplant volume within 1 year. A systematic approach to ECD kidneys based on nephron mass matching and nephron sparing measures may provide optimal utilization with short-term outcomes and renal function comparable to SCD kidneys.</description><subject>Aged</subject><subject>Creatinine - blood</subject><subject>Female</subject><subject>Graft Survival</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Transplantation - immunology</subject><subject>Kidney Transplantation - methods</subject><subject>Kidney Transplantation - statistics &amp; numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original and Discussions</subject><subject>Retrospective Studies</subject><subject>Tissue Donors</subject><subject>Treatment Outcome</subject><issn>0003-4932</issn><issn>1528-1140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkcGOFCEURYnROO3oLxjiwl2VPKgqwIWJmeg4ySRudE0ooHrQaiiBGh2_wk8e2u447duweOfe-8hF6BWQFojkbwi0edYtqQO0o3Jou4EDbQf-CG2gp6IB6MhjtKkAazrJ6Bl6lvO3ineC8KfoDHoiqORsg_5cBZOczs7i794Gd4dL0iEvsw5FFx8DXouf_W8fttj9WnSwlTTJF5e8xtaZgzamrQ7YxhBTxj99ucHJ5XUuGZu4W3TS4-xwiTiX6qDTqcVecxL6HD2Z9Jzdi-N7jr5-_PDl4lNz_fny6uL9dWM62pVmIFRKK81oO2r1xCY9mIkC5VJIIRjlYrQG-n4ijFg9MpBUEzDGUuEsF8DO0buD77KOO2eNC_WGWS3J73S6U1F79f8m-Bu1jbcKWD9QzqvB66NBij9Wl4va-WzcXD_h4poVB8FYD6yCbw-gSTHn5KZ_IUDUvlBFQNVC1UOh6m-hatinvDw980F6bJDdA4zdo5A</recordid><startdate>200405</startdate><enddate>200405</enddate><creator>Stratta, Robert J</creator><creator>Rohr, Michael S</creator><creator>Sundberg, Aimee K</creator><creator>Armstrong, Greg</creator><creator>Hairston, Gloria</creator><creator>Hartmann, Erica</creator><creator>Farney, Alan C</creator><creator>Roskopf, Julie</creator><creator>Iskandar, Samy S</creator><creator>Adams, Patricia L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200405</creationdate><title>Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant</title><author>Stratta, Robert J ; Rohr, Michael S ; Sundberg, Aimee K ; Armstrong, Greg ; Hairston, Gloria ; Hartmann, Erica ; Farney, Alan C ; Roskopf, Julie ; Iskandar, Samy S ; Adams, Patricia L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-60299d9cbd42daf3fa6cf2127989883278bdc155f030dab3192a01ccd28ed7813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Creatinine - blood</topic><topic>Female</topic><topic>Graft Survival</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Transplantation - immunology</topic><topic>Kidney Transplantation - methods</topic><topic>Kidney Transplantation - statistics &amp; numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original and Discussions</topic><topic>Retrospective Studies</topic><topic>Tissue Donors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stratta, Robert J</creatorcontrib><creatorcontrib>Rohr, Michael S</creatorcontrib><creatorcontrib>Sundberg, Aimee K</creatorcontrib><creatorcontrib>Armstrong, Greg</creatorcontrib><creatorcontrib>Hairston, Gloria</creatorcontrib><creatorcontrib>Hartmann, Erica</creatorcontrib><creatorcontrib>Farney, Alan C</creatorcontrib><creatorcontrib>Roskopf, Julie</creatorcontrib><creatorcontrib>Iskandar, Samy S</creatorcontrib><creatorcontrib>Adams, Patricia L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stratta, Robert J</au><au>Rohr, Michael S</au><au>Sundberg, Aimee K</au><au>Armstrong, Greg</au><au>Hairston, Gloria</au><au>Hartmann, Erica</au><au>Farney, Alan C</au><au>Roskopf, Julie</au><au>Iskandar, Samy S</au><au>Adams, Patricia L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant</atitle><jtitle>Annals of surgery</jtitle><addtitle>Ann Surg</addtitle><date>2004-05</date><risdate>2004</risdate><volume>239</volume><issue>5</issue><spage>688</spage><epage>697</epage><pages>688-697</pages><issn>0003-4932</issn><eissn>1528-1140</eissn><abstract>To compare outcomes in recipients of expanded criteria donor (ECD) versus standard criteria donor (SCD) kidneys at a single center using a standardized approach with similar immunosuppression. Expanded criteria deceased organ donors (ECD) are a source of kidneys that permit more patients to benefit from transplantation. ECD is defined as all deceased donors older than 60 years and donors older than 50 years with 2 of the following: hypertension, stroke as the cause of death, or pre-retrieval serum creatinine (SCr) greater than 1.5 mg/dl. We retrospectively studied 90 recipients of adult deceased donor kidneys transplanted from October 1, 2001 to February 17, 2003, including 37 (41%) from ECDs and 53 (59%) from SCDs. ECD kidneys were used by matching estimated renal functional mass to recipient need, including the use of dual kidney transplants (n = 7). ECD kidney recipients were further selected on the basis of older age, HLA-matching, low allosensitization, and low body mass index. All patients received a similar immunosuppressive regimen. Minimum follow up was 9 months. There were significant differences in donor and recipient characteristics between ECD and SCD transplants. Patient (99%) and kidney graft survival (88%) rates and morbidity were similar between the 2 groups, with a mean follow-up of 16 months. Initial graft function and the mean 1-week and 1-, 3-, 6-, 12-, and 18-month SCr levels were similar among groups. The use of ECD kidneys at our center effectively doubled our transplant volume within 1 year. A systematic approach to ECD kidneys based on nephron mass matching and nephron sparing measures may provide optimal utilization with short-term outcomes and renal function comparable to SCD kidneys.</abstract><cop>United States</cop><pmid>15082973</pmid><doi>10.1097/01.sla.0000124296.46712.67</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4932
ispartof Annals of surgery, 2004-05, Vol.239 (5), p.688-697
issn 0003-4932
1528-1140
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1356277
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aged
Creatinine - blood
Female
Graft Survival
Humans
Immunosuppressive Agents - therapeutic use
Kidney Transplantation - immunology
Kidney Transplantation - methods
Kidney Transplantation - statistics & numerical data
Male
Middle Aged
Original and Discussions
Retrospective Studies
Tissue Donors
Treatment Outcome
title Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A11%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20kidney%20transplantation%20utilizing%20expanded%20criteria%20deceased%20organ%20donors%20with%20results%20comparable%20to%20standard%20criteria%20donor%20transplant&rft.jtitle=Annals%20of%20surgery&rft.au=Stratta,%20Robert%20J&rft.date=2004-05&rft.volume=239&rft.issue=5&rft.spage=688&rft.epage=697&rft.pages=688-697&rft.issn=0003-4932&rft.eissn=1528-1140&rft_id=info:doi/10.1097/01.sla.0000124296.46712.67&rft_dat=%3Cproquest_pubme%3E71833513%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71833513&rft_id=info:pmid/15082973&rfr_iscdi=true